| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO, Treasurer &Secretary
2 companies
Leverone Jason A. serves as a CFO, Treasurer &Secretary at VRDN and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $1.2M at current prices.
Historically, Leverone Jason A.'s trades have earned a below-average insider score of 31/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -50.7%.
The biggest single holding is VRDN (~$1.1M) as CFO, Treasurer &Secretary.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | OKUR Onkure Therapeutics, Inc. | Chief Financial Officer | Sell | 301 | $4.16 | $1,251.11 | -1.8% | +12.6% | - | |
| Dec 22, 2025 | OKUR Onkure Therapeutics, Inc. | Chief Financial Officer | Sell | 302 | $2.97 | $896.25 | -1.8% | +34.5% | - | |
| Sep 22, 2025 | OKUR Onkure Therapeutics, Inc. | Chief Financial Officer | Sell | 303 | $2.62 | $794.92 | -2.3% | +13.4% | - | |
| Jun 23, 2025 | OKUR Onkure Therapeutics, Inc. | Chief Financial Officer | Sell | 303 | $2.38 | $722.41 | -2.3% | +8.3% | +74.3% | |
| Apr 7, 2025 | OKUR Onkure Therapeutics, Inc. | Chief Financial Officer | Sell | 3,122 | $2.94 | $9,178.00 | -9.9% | -22.7% | +38.8% |